Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Kraig Biocraft LaboratoriesKBLB -0.34%30 Current Ratio is 0.28 as of Mar. 2026, which is 115% above its 10-year median of 0.13. GuruFocus rates KBLB with a GF Score™ of 30/100. The stock has 2 warning signs investors should review. Among 1,605 Chemicals companies, Kraig Biocraft Laboratories ranks worse than 98.38% on this metric.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Kraig Biocraft Laboratories's current ratio for the quarter that ended in Mar. 2026 was 0.28.
Kraig Biocraft Laboratories has a current ratio of 0.28. It indicates that the company may have difficulty meeting its current obligations. Low values, however, do not indicate a critical problem. If Kraig Biocraft Laboratories has good long-term prospects, it may be able to borrow against those prospects to meet current obligations.
The historical rank and industry rank for Kraig Biocraft Laboratories's Current Ratio or its related term are showing as below:
KBLB'
s Current Ratio Range Over the Past 10 Years
Min: 0.01 Med: 0.13 Max: 0.53
Current: 0.28
During the past 13 years, Kraig Biocraft Laboratories's highest Current Ratio was 0.53. The lowest was 0.01. And the median was 0.13.
KBLB's Current Ratio is ranked worse than 98.38% of 1605
companies
in the Chemicals industry
Industry Median: 1.89
vs KBLB: 0.28
Kraig Biocraft Laboratories (OTCPK:KBLB) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
Kraig Biocraft Laboratories Current Ratio Related Terms
Kraig Biocraft Laboratories Current Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Specialty Chemicals subindustry, Kraig Biocraft Laboratories's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kraig Biocraft Laboratories Current Ratio vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Kraig Biocraft Laboratories's Current Ratio distribution charts can be found below:
* The bar in red indicates where Kraig Biocraft Laboratories's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kraig Biocraft Laboratories (KBLB) has a Current Ratio of 0.28 as of Mar. 2026. This is 115% above median its historical median of 0.13. Over the past decade, Kraig Biocraft Laboratories' Current Ratio has ranged from 0.01 to 0.53. According to the industry distribution chart, Kraig Biocraft Laboratories ranks #1579 out of 1605 companies in the Chemicals industry, placing it in the top 98.4%.
Is Kraig Biocraft Laboratories' Current Ratio too high?
Kraig Biocraft Laboratories' current Current Ratio of 0.28 is 115% above median its 10-year median of 0.13. Over the past 10 years, this metric has ranged from a low of 0.01 to a high of 0.53. The Chemicals industry median Current Ratio is 1.89. Kraig Biocraft Laboratories' value of 0.28 is 85.2% below this industry median. Based on the distribution chart, Kraig Biocraft Laboratories ranks #1579 out of 1605 companies in the Chemicals industry, which is in the bottom quartile relative to peers. Overall, Kraig Biocraft Laboratories has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Kraig Biocraft Laboratories' Current Ratio compare to AMTX and FSI?
According to the Chemicals industry distribution chart, Kraig Biocraft Laboratories ranks #1579 out of 1605 companies for Current Ratio. This places Kraig Biocraft Laboratories in the lower half of its industry. The industry median Current Ratio is 1.89. Kraig Biocraft Laboratories' value of 0.28 is 85.2% below this benchmark. Historically, Kraig Biocraft Laboratories' own Current Ratio has ranged from 0.01 to 0.53 over the past decade. While the company's 10-year median is 0.13 vs. the industry median of 1.89, Kraig Biocraft Laboratories has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Chemicals company?
The median Current Ratio among Chemicals companies is 1.89, based on 1,605 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Kraig Biocraft Laboratories's current Current Ratio of 0.28 is 85.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Chemicals industry, the median Current Ratio is 1.89 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Kraig Biocraft Laboratories's current Current Ratio is 0.28, which is 115% above median its own 10-year median of 0.13. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kraig Biocraft Laboratories stock overvalued right now?
Kraig Biocraft Laboratories (KBLB) has a current Current Ratio of 0.28. The current Current Ratio is 0.28, which is 115% above median its 10-year median of 0.13 and 85.2% below the Chemicals industry median of 1.89. Kraig Biocraft Laboratories' overall GF Score™ is 30/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Kraig Biocraft Laboratories (KBLB), the current Current Ratio is 0.28 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Kraig Biocraft Laboratories Inc is engaged in the development of high-strength fiber using recombinant DNA technology mainly for commercial applications. It uses genetic engineering technologies to develop fibers with greater strength, resiliency, and flexibility for use in its target markets, namely the textile, specialty fiber, and technical textile industries. Its products include Monster Silk, which incorporates the natural elasticity of spider silk to make a silk fiber that is more flexible than conventional silk fibers and textiles; Dragon Silk, which combines the elasticity of Monster Silk with additional high-strength elements of native spider silk; Spydasilk; and Spydra.
30GF Score
Get the complete analysis for KBLB
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
KBLB has been successfully added to your 
